SOLV
Solventum Corporation
Is SOLV Halal?
Healthcare products spun from 3M with generally permissible business.
What You Should Know
Solventum (former 3M Health Care) provides medical and surgical supplies, infection prevention, dental products and health information systems. Its March 31, 2026 Form 10-Q reports $14,097 million of assets, $5,287 million of interest-bearing debt including finance leases, $561 million of cash, $1,059 million of receivables and $2,007 million of quarterly sales. Debt/assets is 37.50%, above the examined FTSE, MSCI and Malaysia asset limits; interest income is not separately disclosed within $62 million of interest expense, net, so the quantitative screen fails.
⚠️ Concerns
- •Medical and dental product end uses
- •Health-information software and patient data
- •Debt/assets above examined limits
- •Interest income is not separately quantified
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
5,287 / 14,097
561 / 14,097
1,620 / 14,097
- Financial
- Fails
- Overall
- Fails
Debt/assets is 37.50%, above the examined FTSE 33.333% limit; liquidity/assets is 3.98% and receivables-plus-cash/assets is 11.49%. The income input is unavailable.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 37.50%, above the examined MSCI 33.33% total-assets limit; the debt failure is independent of the unavailable income input.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 37.50%, above the examined Malaysia 33% limit; this is a calculation against the named ratios, not an official classification.
- Financial
- Not calculated
- Overall
- Fails
A licensed historical market-cap series is not stored; the debt screen fails independently.
Business-activity disclosure
Solventum provides medical, dental, infection-prevention and health-information products and software. The core activity is generally permissible.
Limitation: The filing does not allocate every medical, dental, software, patient or customer end use into a scholar-approved prohibited-revenue numerator.
Purification
Solventum reports $62 million of interest expense, net including interest income, but does not separately quantify interest income or provide a scholar-approved purification percentage.
Inputs, assumptions and primary sources
- Amounts are USD millions from Solventum's March 31, 2026 Form 10-Q.
- Interest-bearing debt includes $505 million of short-term borrowings/current maturities, $4,575 million of long-term debt and $207 million of finance leases; operating leases are excluded.
- Cash is $561 million; the filing reports immaterial marketable securities and they are not counted in the selected proxy.
- Accounts receivable are $1,059 million net; first-quarter net sales are $2,007 million.
- Interest expense, net is $62 million and includes interest accrued on debt offset by interest income; interest income is not separately quantified, so the income input is unavailable.
- Medical, dental, infection-prevention and health-information products are treated as generally permissible; software, patient and customer end uses remain qualitative review items.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →